
Candid Therapeutics recorded San Diego's largest venture capital deal during the third quarter.
{ "@context": "http:\/\/schema.org", "@type": "Article", "image": "https:\/\/sandiegouniontribune.diariosergipano.net\/wp-content\/s\/2024\/10\/sut-l-q2-venture_NEL-014.jpg?w=150&strip=all", "headline": "San Diego\u2019s life science startups continue to drive more than $1B in venture capital deals", "datePublished": "2024-10-17 12:38:47", "author": { "@type": "Person", "workLocation": { "@type": "Place" }, "Point": { "@type": "Point", "Type": "Journalist" }, "sameAs": [ "https:\/\/sandiegouniontribune.diariosergipano.net\/author\/natallie-rochasduniontribune-com\/" ], "name": "Natallie Rocha" } }
Skip to contentCandid Therapeutics recorded San Diego's largest venture capital deal during the third quarter.